919 related articles for article (PubMed ID: 20621050)
1. A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts.
Li R; Liang J; Ni S; Zhou T; Qing X; Li H; He W; Chen J; Li F; Zhuang Q; Qin B; Xu J; Li W; Yang J; Gan Y; Qin D; Feng S; Song H; Yang D; Zhang B; Zeng L; Lai L; Esteban MA; Pei D
Cell Stem Cell; 2010 Jul; 7(1):51-63. PubMed ID: 20621050
[TBL] [Abstract][Full Text] [Related]
2. Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming.
Samavarchi-Tehrani P; Golipour A; David L; Sung HK; Beyer TA; Datti A; Woltjen K; Nagy A; Wrana JL
Cell Stem Cell; 2010 Jul; 7(1):64-77. PubMed ID: 20621051
[TBL] [Abstract][Full Text] [Related]
3. Reprogramming induced pluripotent stem cells in the absence of c-Myc for differentiation into hepatocyte-like cells.
Li HY; Chien Y; Chen YJ; Chen SF; Chang YL; Chiang CH; Jeng SY; Chang CM; Wang ML; Chen LK; Hung SI; Huo TI; Lee SD; Chiou SH
Biomaterials; 2011 Sep; 32(26):5994-6005. PubMed ID: 21658760
[TBL] [Abstract][Full Text] [Related]
4. Enhanced human somatic cell reprogramming efficiency by fusion of the MYC transactivation domain and OCT4.
Wang L; Huang D; Huang C; Yin Y; Vali K; Zhang M; Tang Y
Stem Cell Res; 2017 Dec; 25():88-97. PubMed ID: 29125994
[TBL] [Abstract][Full Text] [Related]
5. OCT4 activity during conversion of human intermediately reprogrammed stem cells to iPSCs through mesenchymal-epithelial transition.
Teshigawara R; Hirano K; Nagata S; Ainscough J; Tada T
Development; 2016 Jan; 143(1):15-23. PubMed ID: 26657769
[TBL] [Abstract][Full Text] [Related]
6. Sequential introduction of reprogramming factors reveals a time-sensitive requirement for individual factors and a sequential EMT-MET mechanism for optimal reprogramming.
Liu X; Sun H; Qi J; Wang L; He S; Liu J; Feng C; Chen C; Li W; Guo Y; Qin D; Pan G; Chen J; Pei D; Zheng H
Nat Cell Biol; 2013 Jul; 15(7):829-38. PubMed ID: 23708003
[TBL] [Abstract][Full Text] [Related]
7. Manipulation of KLF4 expression generates iPSCs paused at successive stages of reprogramming.
Nishimura K; Kato T; Chen C; Oinam L; Shiomitsu E; Ayakawa D; Ohtaka M; Fukuda A; Nakanishi M; Hisatake K
Stem Cell Reports; 2014 Nov; 3(5):915-29. PubMed ID: 25418733
[TBL] [Abstract][Full Text] [Related]
8. Generation of iPSCs from mouse fibroblasts with a single gene, Oct4, and small molecules.
Li Y; Zhang Q; Yin X; Yang W; Du Y; Hou P; Ge J; Liu C; Zhang W; Zhang X; Wu Y; Li H; Liu K; Wu C; Song Z; Zhao Y; Shi Y; Deng H
Cell Res; 2011 Jan; 21(1):196-204. PubMed ID: 20956998
[TBL] [Abstract][Full Text] [Related]
9. Generation of Human iPSCs by Episomal Reprogramming of Skin Fibroblasts and Peripheral Blood Mononuclear Cells.
Febbraro F; Chen M; Denham M
Methods Mol Biol; 2021; 2239():135-151. PubMed ID: 33226617
[TBL] [Abstract][Full Text] [Related]
10. NKX3-1 is required for induced pluripotent stem cell reprogramming and can replace OCT4 in mouse and human iPSC induction.
Mai T; Markov GJ; Brady JJ; Palla A; Zeng H; Sebastiano V; Blau HM
Nat Cell Biol; 2018 Aug; 20(8):900-908. PubMed ID: 30013107
[TBL] [Abstract][Full Text] [Related]
11. Generation of induced pluripotent stem cells from buffalo (Bubalus bubalis) fetal fibroblasts with buffalo defined factors.
Deng Y; Liu Q; Luo C; Chen S; Li X; Wang C; Liu Z; Lei X; Zhang H; Sun H; Lu F; Jiang J; Shi D
Stem Cells Dev; 2012 Sep; 21(13):2485-94. PubMed ID: 22420535
[TBL] [Abstract][Full Text] [Related]
12. OCT4 and SOX2 Work as Transcriptional Activators in Reprogramming Human Fibroblasts.
Narayan S; Bryant G; Shah S; Berrozpe G; Ptashne M
Cell Rep; 2017 Aug; 20(7):1585-1596. PubMed ID: 28813671
[TBL] [Abstract][Full Text] [Related]
13. Excluding Oct4 from Yamanaka Cocktail Unleashes the Developmental Potential of iPSCs.
Velychko S; Adachi K; Kim KP; Hou Y; MacCarthy CM; Wu G; Schöler HR
Cell Stem Cell; 2019 Dec; 25(6):737-753.e4. PubMed ID: 31708402
[TBL] [Abstract][Full Text] [Related]
14. p73 is required for appropriate BMP-induced mesenchymal-to-epithelial transition during somatic cell reprogramming.
Martin-Lopez M; Maeso-Alonso L; Fuertes-Alvarez S; Balboa D; Rodríguez-Cortez V; Weltner J; Diez-Prieto I; Davis A; Wu Y; Otonkoski T; Flores ER; Menéndez P; Marques MM; Marin MC
Cell Death Dis; 2017 Sep; 8(9):e3034. PubMed ID: 28880267
[TBL] [Abstract][Full Text] [Related]
15. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
[TBL] [Abstract][Full Text] [Related]
16. C/EBPα poises B cells for rapid reprogramming into induced pluripotent stem cells.
Di Stefano B; Sardina JL; van Oevelen C; Collombet S; Kallin EM; Vicent GP; Lu J; Thieffry D; Beato M; Graf T
Nature; 2014 Feb; 506(7487):235-9. PubMed ID: 24336202
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional Reactivation of OTX2, RX1 and SIX3 during Reprogramming Contributes to the Generation of RPE Cells from Human iPSCs.
Li P; Sun X; Ma Z; Liu Y; Jin Y; Ge R; Hao L; Ma Y; Han S; Sun H; Zhang M; Li R; Li T; Shen L
Int J Biol Sci; 2016; 12(5):505-17. PubMed ID: 27019633
[TBL] [Abstract][Full Text] [Related]
18. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells.
Tiemann U; Sgodda M; Warlich E; Ballmaier M; Schöler HR; Schambach A; Cantz T
Cytometry A; 2011 Jun; 79(6):426-35. PubMed ID: 21548079
[TBL] [Abstract][Full Text] [Related]
19. Activation of AMP-activated protein kinase (AMPK) provides a metabolic barrier to reprogramming somatic cells into stem cells.
Vazquez-Martin A; Vellon L; Quirós PM; Cufí S; Ruiz de Galarreta E; Oliveras-Ferraros C; Martin AG; Martin-Castillo B; López-Otín C; Menendez JA
Cell Cycle; 2012 Mar; 11(5):974-89. PubMed ID: 22333578
[TBL] [Abstract][Full Text] [Related]
20. OSKM Induce Extraembryonic Endoderm Stem Cells in Parallel to Induced Pluripotent Stem Cells.
Parenti A; Halbisen MA; Wang K; Latham K; Ralston A
Stem Cell Reports; 2016 Apr; 6(4):447-455. PubMed ID: 26947975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
